Structure-activity relationship studies of G9a-like protein (GLP) inhibitors. Read more about Structure-activity relationship studies of G9a-like protein (GLP) inhibitors.
Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancer. Read more about Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancer.
Global analysis of protein folding using massively parallel design, synthesis, and testing. Read more about Global analysis of protein folding using massively parallel design, synthesis, and testing.
NEK1 kinase domain structure and its dynamic protein interactome after exposure to Cisplatin. Read more about NEK1 kinase domain structure and its dynamic protein interactome after exposure to Cisplatin.
ASCL1 Reorganizes Chromatin to Direct Neuronal Fate and Suppress Tumorigenicity of Glioblastoma Stem Cells. Read more about ASCL1 Reorganizes Chromatin to Direct Neuronal Fate and Suppress Tumorigenicity of Glioblastoma Stem Cells.
Design of a chemical probe for the Bromodomain and Plant Homeodomain Finger-containing (BRPF) family of proteins. Read more about Design of a chemical probe for the Bromodomain and Plant Homeodomain Finger-containing (BRPF) family of proteins.
BRD3 and BRD4 BET Bromodomain Proteins Differentially Regulate Skeletal Myogenesis. Read more about BRD3 and BRD4 BET Bromodomain Proteins Differentially Regulate Skeletal Myogenesis.
IDUA mutational profile and genotype-phenotype relationships in UK patients with Mucopolysaccharidosis I. Read more about IDUA mutational profile and genotype-phenotype relationships in UK patients with Mucopolysaccharidosis I.
(19) F NMR isotropic chemical shift for efficient screening of fluorinated fragments which are racemates and/or display multiple conformers. Read more about (19) F NMR isotropic chemical shift for efficient screening of fluorinated fragments which are racemates and/or display multiple conformers.
Progress towards a public chemogenomic set for protein kinases and a call for contributions. Read more about Progress towards a public chemogenomic set for protein kinases and a call for contributions.
